Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells

Cancer Research

Volumn 65, Issue 8, 2005, Pages 3155-3161

  Rambhatla, Lakshmi ^a,b   Ram Mohan, Sumati ^a   Cheng, Jennifer J ^a   Sherley, James L ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b GERON CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE; INOSINATE DEHYDROGENASE; PROTEIN P53;

ADULT; ARTICLE; AUTOREGULATION; BIOENGINEERING; BIOSYNTHESIS; CANCER CELL CULTURE; CANCER GENETICS; CELL ACTIVITY; CELL IMMORTALIZATION; CELL KINETICS; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DNA STRAND; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN P53 GENE; QUANTITATIVE ANALYSIS; SEGREGATION ANALYSIS; STEM CELL;

EID: 17144373352     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3161     Document Type: Article

References (38)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
2. Al-Hajj M, Becker MW, Wicha M. Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 2004;14:43-7.
3. Cairns J. Mutation selection and the natural history of cancer. Nature 1975;255:197-200.
4. Knudson AG. Stem cell regulation, tissue ontogeny, and oncogenic events. Semin Cancer Biol 1992;3:99-106.
5. Sherley JL, Stadler PB, Johnson DR. Expression of the wild-type p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics. Proc Natl Acad Sci U S A 1995;92:136-40.
6. Sherley JL. Tumor suppressor genes and cell kinetics in the etiology of malignant mesothelioma. In: Peters GA and Peters BJ, editors. Asbestos disease control, sourcebook on asbestos diseases. Vol. 21. Santa Monica: Peters and Peters; 2000. p. 91-141.
7. Potten CS, Booth C, Hargreaves D. The small intestine as a model for evaluation of adult tissue stem cell drug targets. Cell Prolif 2003;36:115-29.
8. Sherley JL. The p53 tumor suppressor gene as regulator of somatic stem cell renewal division. Cope 1996;12:9-10.
9. Loeffler M, Potten CS. Stem cells and cellular pedigrees: a conceptual introduction. In: Potten CS, editor. Stem cells. San Diego (CA): Harcourt Brace and Co.; 1997. p. 1-28.
10. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 2002;24:91-8.
11. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 2002;115:2381-8.
12. Merok JR, Lansita JA, Tunstead JR, Sherley JL. Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics. Cancer Res 2002;62:6791-5.
13. Sherley JL. Asymmetric cell kinetics genes: the key to expansion of adult stem cells in culture. Stem Cells 2002;20:561-72.
14. Liu Y, Riley LB, Bohn SA, Boice JA, Stadler PB, Sherley JL. Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions. J Cell Physiol 1998;177:364-76.
15. Rambhatla L, Bohn SA, Stadler PB, Boyd JT, Coss RA, Sherley JL. 2001. Cellular senescence: ex vivo p53-dependent asymmetric cell kinetics. J Biomed Biotechnol 2001;1:27-36.
16. Liu Y, Bohn SA, Sherley JL. Inosine-5′-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. Mol Biol Cell 1998;9:15-28.
17. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-35.
18. Kornberg A. DNA replication, ed. 2: San Francisco (CA): W. H. Freeman and Co.; 1980.
19. Lee H-S, Crane GG, Merok JR, et al. Clonal expansion of adult rat hepatic stem cell lines by suppression of asymmetric cell kinetics (SACK). Biotechnol Bioeng 2003;83:760-71.
20. Sherley JL. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J Biol Chem 1991;266:24815-28.
21. Latt SA, George YS, Gray JW. Flow cytometric analysis of bromodeoxyuridine-substituted cells stained with 33258 Hoechst. J Histochem Cytochem 1977;25:927-34.
22. Sherley JL, Stadler PB, Stadler JS. A quantitative method for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells. Cell Prolif 1995b;28:137-44.
23. Stadler PB, Pennacchi J, Sherley JL. Inosine-5′-monophosphate dehydrogenase activity is maintained in immortalized murine cells growth-arrested by serum deprivation. Adv Enzyme Regul 1994;34:91-106.
24. Senda M, Natsumeda Y. Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205). Life Sci 1994;54:1917-26.
25. Natsumeda Y, Ohno S, Kawasaki H, Konno Y, Weber G, Suzuki K. Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem 1990;265:5292-5.
26. Jackson RC, Weber G, Morris HP. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 1975;256:331-3.
27. Nagai M, Natsumeda Y, Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res 1992;52:258-61.
28. Collart FR, Chubb CB, Mirkin BL, Huberman E. Increased inosine-5′-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res 1992;52:5826-8.
29. Maurer SM, Firestone RB, Scriver CR. Science's neglected legacy. Nature 2000;405:117-20.
30. Dearden P, Akam M. Segmentation in silico. Nature 2000;406:131-2.
31. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998;12:2973-83.
32. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
33. Tiedeman AA, Smith JM. Isolation and sequence of a cDNA encoding mouse IMP dehydrogenase. Gene 1991;97:289-93.
34. Merok JR, Sherley JL. Breaching the kinetic barrier to in vitro somatic stem cell propagation. J Biomed Biotechnol 2001;1:24-6.
35. Herrero-Jimenez P, Thilly G, Southam PJ, et al. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States. Mutat Res 1998;400:553-78.
36. Huang S, Law P, Francis K, Palsson BO, Ho AD. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood 1999;94:2595-604.
37. - cells. Exp Hematol 2002;30:464-72.
38. O'Connor PM, Jackman J, Bae I, et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 1997;57:4285-300.